R. Thomas Winters

1.3k total citations
24 papers, 643 citations indexed

About

R. Thomas Winters is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, R. Thomas Winters has authored 24 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 8 papers in Molecular Biology and 3 papers in Spectroscopy. Recurrent topics in R. Thomas Winters's work include Quinazolinone synthesis and applications (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and biological activity (4 papers). R. Thomas Winters is often cited by papers focused on Quinazolinone synthesis and applications (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and biological activity (4 papers). R. Thomas Winters collaborates with scholars based in United States, New Zealand and Canada. R. Thomas Winters's co-authors include H. D. Hollis Showalter, William A. Denny, Gordon W. Rewcastle, Patrick W. Vincent, Dallas K. Bates, David W. Fry, Billy Roberts, James M. Nelson, Brian D. Palmer and Joseph A. Picard and has published in prestigious journals such as Journal of the American Chemical Society, Journal of the American College of Cardiology and Journal of Medicinal Chemistry.

In The Last Decade

R. Thomas Winters

23 papers receiving 604 citations

Peers

Countries citing papers authored by R. Thomas Winters

Since Specialization

Citations

This map shows the geographic impact of R. Thomas Winters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Thomas Winters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Thomas Winters more than expected).

Fields of papers citing papers by R. Thomas Winters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Thomas Winters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Thomas Winters. The network helps show where R. Thomas Winters may publish in the future.

Co-authorship network of co-authors of R. Thomas Winters

This figure shows the co-authorship network connecting the top 25 collaborators of R. Thomas Winters. A scholar is included among the top collaborators of R. Thomas Winters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Thomas Winters. R. Thomas Winters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EOSINOPHILIC MYOCARDITIS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANCA ASSCOCIATED VASCULITIS OVERLAP 2023 ·Journal of the American College of Cardiology ·(unknown), R. Thomas Winters, (unknown), (unknown), Natasha Altman, William K. Cornwell	0
2	DFTMP, an NMR Reagent for Assessing the Near-Neutral pH of Biological Samples 2006 ·Journal of the American Chemical Society ·Michael D. Reily, Lora C. Robosky, (unknown), Andrew J. Butler, John D. Baker, R. Thomas Winters	33
3	Evaluation of an integrated in vitro–in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability 2005 ·International Journal of Pharmaceutics ·Hongliang Cai, Chad Stoner, (unknown), (unknown), (unknown), R. Thomas Winters, Charles J. Stankovic, Narayanan Surendran	14
4	Validation of a semi-automated human hepatocyte assay for the determination and prediction of intrinsic clearance in discovery 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Tycho Heimbach, (unknown), (unknown), R. Thomas Winters, (unknown), Narayanan Surendran, Hongliang Cai	23
5	Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity 2001 ·Journal of Medicinal Chemistry ·Mel C. Schroeder, James M. Hamby, Cleo J. C. Connolly, Patrick J. Grohar, R. Thomas Winters, Mark R. Barvian, Charles Watson Moore, (unknown), Sheila Crean, Alan J. Kraker, Denise L. Driscoll, Patrick W. Vincent, William L. Elliott, Gina H. Lu, Brian L. Batley, Tawny K. Dahring, Terry C. Major, Robert L. Panek, Annette M. Doherty, H. D. Hollis Showalter	49
6	Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor 1999 ·Journal of Medicinal Chemistry ·Jeff B. Smaill, Brian D. Palmer, Gordon W. Rewcastle, William A. Denny, Dennis J. McNamara, Ellen M. Dobrusin, Alexander J. Bridges, Hairong Zhou, H. D. Hollis Showalter, R. Thomas Winters, Wilbur R. Leopold, David W. Fry, James M. Nelson, (unknown), (unknown), Billy Roberts, Patrick W. Vincent, (unknown)	158
7	Structure−Activity Relationships for 1-Phenylbenzimidazoles as Selective ATP Site Inhibitors of the Platelet-Derived Growth Factor Receptor 1998 ·Journal of Medicinal Chemistry ·Brian D. Palmer, Jeff B. Smaill, Maruta Boyd, Diane H. Boschelli, Annette M. Doherty, James M. Hamby, (unknown), James B. Kramer, Alan J. Kraker, Robert L. Panek, Gina H. Lu, Tawny K. Dahring, R. Thomas Winters, H. D. Hollis Showalter, William A. Denny	50
8	Tyrosine Kinase Inhibitors. 14. Structure−Activity Relationships for Methyl- amino-Substituted Derivatives of 4-[(3-Bromophenyl)amino]-6-(methylamino)- pyrido[3,4-d]pyrimidine (PD 158780), a Potent and Specific Inhibitor of the Tyrosine Kinase Activity of Receptors for the EGF Family of Growth Factors 1998 ·Journal of Medicinal Chemistry ·Gordon W. Rewcastle, (unknown), William L. Elliott, David W. Fry, (unknown), James M. Nelson, Billy Roberts, Patrick W. Vincent, H. D. Hollis Showalter, R. Thomas Winters, William A. Denny	98
9	Concise Syntheses of the Novel 1H-Pyrrolo[3,2-g]quinazoline Ring System and its [2,3-f] Angular Isomer 1996 ·The Journal of Organic Chemistry ·H. D. Hollis Showalter, (unknown), Anthony D. Sercel, R. Thomas Winters, William A. Denny, Brian D. Palmer	16
10	ChemInform Abstract: Concise Syntheses of the Novel 1H‐Pyrrolo(3,2‐g)quinazoline Ring System and Its (2,3‐f) Angular Isomer. 1996 ·ChemInform ·H. D. Hollis Showalter, Liang Sun, Anthony D. Sercel, R. Thomas Winters, William A. Denny, Brian D. Palmer	1
11	Derivatives of 5-[[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists 1995 ·Journal of Medicinal Chemistry ·Jeremy J. Edmunds, S. KLUTCHKO, James M. Hamby, Amy Bunker, Cleo J. C. Connolly, R. Thomas Winters, (unknown), Ila Sircar, John C. Hodges	20
12	Glutamine protects Chinese hamster ovary cells from radiation killing 1994 ·Life Sciences ·R. Thomas Winters, Richard H. Matthews, Nuran Erçal, (unknown)	5
13	Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-l-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H-imidazole-5-carboxylic acid (CI-996) 1993 ·Journal of Medicinal Chemistry ·Ila Sircar, John C. Hodges, John Quin, Amy Bunker, R. Thomas Winters, Jeremy J. Edmunds, Catherine R. Kostlan, Cleo J. C. Connolly, S. Kesten	5
14	Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists 1993 ·Journal of Medicinal Chemistry ·Ila Sircar, R. Thomas Winters, John Quin, Gina H. Lu, Terry C. Major, Robert L. Panek	12
15	Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors 1992 ·Journal of Medicinal Chemistry ·Annette M. Doherty, Ila Sircar, (unknown), John Quin, R. Thomas Winters, James S. Kaltenbronn, (unknown), Brian L. Batley, (unknown)	52
16	ChemInform Abstract: Intramolecular Capture of Pummerer Rearrangement Intermediates. Part 3. Interrupted Pummerer Rearrangement: Capture of Tricoordinate Sulfur Species Generated Under Pummerer Rearrangement Conditions. 1992 ·ChemInform ·Dallas K. Bates, R. Thomas Winters, (unknown)	1
17	Synthesis and evaluation of a series of 3,5-disubstituted benzisoxazole-4,7-diones. Potent radiosensitizers in vitro 1991 ·Journal of Medicinal Chemistry ·Mark J. Suto, Michael A. Stier, R. Thomas Winters, William R. Turner, (unknown), (unknown), Judith S. Sebolt–Leopold	6
18	Facile synthesis of thioglucose analogs of the anticancer agent etoposide 1991 ·Tetrahedron Letters ·(unknown), R. Thomas Winters, Anthony D. Sercel, A. G. Michel	15
19	ChemInform Abstract: Efficient Synthesis of peri‐Hydroxylated 9,10‐Anthracenedione Ethers (III) ‐ (VI) via Alkylation of Cesium Phenolates. 1989 ·ChemInform ·R. Thomas Winters, Anthony D. Sercel, H. D. Hollis Showalter	1
20	Efficient Synthesis ofperi-Hydroxylated 9,10-Anthracenedione Ethers via Alkylation of Cesium Phenolates 1988 ·Synthesis ·R. Thomas Winters, Anthony D. Sercel, H. D. Hollis Showalter	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact